Vivos Inc (RDGL) stock
RDGLOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.05−0.00 (-2.51%)
Close on Oct 19, 2026Market cap $23.44MP/E –Yield –
Vivos gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Vivos's gross profit for the twelve months ending Jun 30, 2026 was -$25.66K. For fiscal 2025 it was -$59.76K. The highest annual figure on record is $329.56K in fiscal 2011.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$59.76K | – |
| FY2024 | Dec 31, 2024 | -$2.98K | – |
| FY2023 | Dec 31, 2023 | -$6.04K | -178.2% |
| FY2022 | Dec 31, 2022 | $7.72K | +167.4% |
| FY2021 | Dec 31, 2021 | $2.89K | +107.4% |
| FY2020 | Dec 31, 2020 | $1.39K | -59.9% |
| FY2019 | Dec 31, 2019 | $3.47K | -57.2% |
| FY2016 | Dec 31, 2016 | $8.11K | -65.7% |
| FY2015 | Dec 31, 2015 | $23.63K | +2.7% |
| FY2014 | Dec 31, 2014 | $23.00K | -34.8% |
| FY2013 | Dec 31, 2013 | $35.27K | -79.9% |
| FY2012 | Dec 31, 2012 | $175.15K | -46.9% |
| FY2011 | Dec 31, 2011 | $329.56K | +13.5% |
| FY2010 | Dec 31, 2010 | $290.48K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.72K | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.02K | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.11K | – |
| Q3 FY2025 | Sep 30, 2025 | -$12.82K | -1285.5% |
| Q2 FY2025 | Jun 30, 2025 | -$34.75K | -1377.7% |
| Q1 FY2025 | Mar 31, 2025 | -$9.08K | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.29K | – |
| Q3 FY2024 | Sep 30, 2024 | $1.08K | -84.6% |
| Q2 FY2024 | Jun 30, 2024 | $2.72K | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.50K | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.00K | – |
| Q3 FY2023 | Sep 30, 2023 | $7.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.50K | -129.5% |
| Q1 FY2023 | Mar 31, 2023 | -$1.54K | -115.4% |
| Q4 FY2022 | Dec 31, 2022 | -$4.23K | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.54K | -173.5% |
| Q2 FY2022 | Jun 30, 2022 | $8.48K | – |
| Q1 FY2022 | Mar 31, 2022 | $10.00K | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.00K | – |
| Q3 FY2021 | Sep 30, 2021 | $8.89K | – |
See a number that looks wrong?